Cognoptix cognoptix.com


Public list: Medical Devices (6146) Neuroscience Startups (942)

Cognoptix, formerly Neuroptix, is a privately held medical technology company headquartered in Acton, Mass., focused on developing and commercializing an in-office, drug/device diagnostic system as an aid in the early detection of Alzheimer's Disease (AD).

Cognoptix, formerly Neuroptix, is a privately held medical technology company headquartered in Acton, Mass., focused on developing and commercializing an in-office, drug/device diagnostic system as an aid in the early detection of Alzheimer's Disease...Show all

Company (Alive / Active)

Phone: 978-263-0005

Fax:

20 Main Street

Acton, 01720
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cognoptix $40.8M Oct 1, 2014
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cognoptix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors

Competitors

Company Status Description Investors

Satoris

Redwood City, California, United States
Alive / ActiveSatoris develops tests for neurological diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, and Diabetic Neuropathy. The company is developing and commercializing neurodiagnostic tests that aim to yield the earliest, most accurate, and most clinically relevant diagnoses, so that healthcare costs can be reduced while patient care becomes even more effective.Login to see details

Avid Radiopharmaceuticals

Philadelphia, Pennsylvania, United States
AcquiredAvid is a clinical-stage product-focused molecular imaging company with IP in the field of molecular brain imaging. Per the company, Avid has developed targeting agents to image amyloid plaques and aims to leverage these compounds for the detection of Alzheimer's disease. Avid is also developing agents targeted to the vesicular monoamine transporter (VMAT-2) to image pathology in dementia with Lewy bodies (DLB), Parkinson's disease (PD), and is also involved in research related to diabetes mel...Show allLogin to see details
See all 18 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
System and method for detecting amyloid proteins Dec 01, 2015 Sep 27, 2016 Patent
System and method for detecting amyloid proteins Aug 12, 2011 Dec 29, 2015 Patent
Ocular imaging Mar 27, 2009 Feb 17, 2015 Patent
Ocular imaging Oct 04, 2010 Mar 05, 2013 Patent
Methods of preparing ophthalmic formulations and uses of same Jan 08, 2018 Application
See all 7 patents